CureVac N.V (NASDAQ: CVAC) on Friday, plunged -4.87% from the previous trading day, before settling in for the closing price of $2.67. Within the past 52 weeks, CVAC’s price has moved between $2.21 and $6.30.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 54.58% over the last five years. The company achieved an average annual earnings per share of 153.37%. With a float of $93.63 million, this company’s outstanding shares have now reached $223.99 million.
The firm has a total of 1172 workers. Let’s measure their productivity. In terms of profitability, gross margin is -154.99%, operating margin of -446.35%, and the pretax margin is -419.84%.
CureVac N.V (CVAC) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of CureVac N.V is 58.26%, while institutional ownership is 5.18%. The most recent insider transaction that took place on Sep 27 ’24, was worth 169. Before that another transaction happened on Sep 25 ’24, when Company’s affiliate proposed sale 34,000 for $3.10, making the entire transaction worth $105,400.
CureVac N.V (CVAC) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 153.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -10.76% during the next five years compared to -23.15% drop over the previous five years of trading.
CureVac N.V (NASDAQ: CVAC) Trading Performance Indicators
CureVac N.V (CVAC) is currently performing well based on its current performance indicators. A quick ratio of 6.19 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.91. Likewise, its price to free cash flow for the trailing twelve months is 4.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.54, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.50 in one year’s time.
Technical Analysis of CureVac N.V (CVAC)
Analysing the last 5-days average volume posted by the [CureVac N.V, CVAC], we can find that recorded value of 0.74 million was lower than the volume posted last year of 0.85 million. As of the previous 9 days, the stock’s Stochastic %D was 20.08%. Additionally, its Average True Range was 0.16.
During the past 100 days, CureVac N.V’s (CVAC) raw stochastic average was set at 2.92%, which indicates a significant decrease from 7.55% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.87% in the past 14 days, which was lower than the 53.88% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.93, while its 200-day Moving Average is $3.21. Now, the first resistance to watch is $2.64. This is followed by the second major resistance level at $2.75. The third major resistance level sits at $2.82. If the price goes on to break the first support level at $2.47, it is likely to go to the next support level at $2.40. Now, if the price goes above the second support level, the third support stands at $2.29.
CureVac N.V (NASDAQ: CVAC) Key Stats
Market capitalization of the company is 542.00 million based on 223,880K outstanding shares. Right now, sales total 58,180 K and income totals -281,580 K. The company made 15,550 K in profit during its latest quarter, and -78,120 K in sales during its previous quarter.
